General Information

Registration fees

All fees in pounds sterling (GBP). Registrations are received by Lena UK.

Register at bronchiectasis-rti.org/2027. Payments are in GBP. A handling fee of £18.00 (VAT included) applies to credit card and cash, and £48.00 (VAT included) to bank transfer. Healthcare professional rates include VAT at 20%. Industry rates are quoted exclusive of VAT.

Healthcare professionals

Registration Fees for Healthcare Professionals

Registration Fee
(VAT INCLUDED)

EBROW ONLY

RTI ONLY

EBROW + RTI

8–10 February

9–11 February

8–11 February

Medical Doctors
Researchers
Healthcare Professionals

Early Fee

(Until 16 Dec 2026)

£410

Early Fee

(Until 16 Dec 2026)

£370

Early Fee

(Until 16 Dec 2026)

£580

General / On-site Fee
(From 17 Dec 2026)

£540

General / On-site Fee
(From 17 Dec 2026)

£480

General / On-site Fee
(From 17 Dec 2026)

£760

Trainees, Students & Early-Career Professionals (<40)(1)

Nurses, Allied Healthcare & Laboratory Professionals (2)

Early Fee
(Until 16 Dec 2026)

£200

Early Fee
(Until 16 Dec 2026)

£200

Early Fee
(Until 16 Dec 2026)

£250

General / On-site Fee
(From 17 Dec 2026)

£250

General / On-site Fee
(From 17 Dec 2026)

£250

General / On-site Fee
(From 17 Dec 2026)

£290

(1) Applies to individuals under 40 years of age on the day of registration, as well as residents, fellows, trainees, and students.
Please upload (during registration fee selection) either a copy of an official document indicating your date of birth or a letter from your employer confirming your training status to be eligible for this discount.
Without the required documentation, the delegate will be charged the standard rate.

(2) Applies to nurses, nurse practitioners, clinical nurse specialists, occupational therapists, physiotherapists and laboratory technicians.

Industry professionals

Registration Fees for Industry Professionals

Registration Fee
(VAT NOT INCLUDED)

EBROW + RTI

8–11 February

Industry Representatives (3)

Early / General / On-site Fee
£1,000

Non-Healthcare Industry Professionals (3)

Early / General / On-site Fee

£3,500

Press

(You must email qualifying credentials to apply for press registration)

(3) INDUSTRY FEES:

There are two types of industry registration fees: Healthcare and Non-Healthcare.

Healthcare Industry Registration applies to healthcare-related professionals and staff from pharmaceutical, biotechnology, medical device, diagnostics, or medical education companies.

Non-Healthcare Industry Registration applies to professionals from non-healthcare sectors, such as financial analysts, non-medical consultants, and staff from communication or marketing agencies, etc.

What is included

EARLY / GENERAL / ON-SITE FEE REGISTRATION FEE INCLUDES

EBROW ONLY

RTI ONLY

EBROW + RTI

8–10 Feb

9–11 Feb

8–11 Feb

Attendance to the Scientific sessions 8-9-10 February

Attendance to the Scientific sessions 9-10-11 February

Attendance to the Scientific sessions

Congress kit EBROW+RTI (same one)

Congress kit EBROW+RTI (same one)

Congress kit EBROW+RTI (same one)

Welcome reception 9 February

Welcome reception 9 February

Welcome reception 9 February

Lunch and refreshments as detailed in the scientific programme

Lunch and refreshments as detailed in the scientific programme

Lunch and refreshments as detailed in the scientific programme

Entrance to the Poster Area & Exhibition 8-9-10 February

Entrance to the Poster Area & Exhibition 9-10-11 February

Entrance to the Poster Area & Exhibition 8-9-10-11 February

Registration

GENERAL REGISTRATION INFORMATION

All registrations must be made through the website http://bronchiectasis-rti.org/2027

All payments must be made in pounds sterling (GBP).

A handling fee of £ 18.00 (VAT included) applies to registrations paid by credit card and cash, and £48,00 (VAT included) for registrations paid by bank transfer. Rates are inclusive of VAT calculated at 20%. In case of fluctuations in VAT the Organising Secretariat adjusts prices accordingly by informing delegates in writing.
Accepted payment methods: major credit cards and bank transfers. Cash payment can only be accepted on-site where on-site fee will be applicable.

Policies

CANCELLATIONS AND REFUNDS

Cancellation or modification of registration must be sent in writing to the Organising Secretariat at info@bronchiectasi-rti.org

By 16 December 2026 all fees will be refunded minus £ 48.00 (VAT included) for administrative charges
All refunds will be settled after the meeting has been concluded.

From 17 December 2026: no refunds will be made

Name changes will incur a £ 48.00 (VAT included) charge to cover administrative costs

Registration & accommodation

GROUP REGISTRATION & HOTEL ACCOMMODATION

For more information about group registration and hotel accommodation, we kindly ask you to e-mail us at info@bronchiectasi-rti.org.

Scientific Committee member 4
Member · EBROW Scientific Committee

Michal Shteinberg

Carmel Medical Center and the Technion, Haifa

Michal Shteinberg is heading the bronchiectasis and adult CF service in the Pulmonology institute and CF center, Carmel medical center, Haifa, Israel. She is a Clinical Assistant Professor in the Faculty of medicine at the Technion, Israel Institute of Technology. Her main research interests are bronchiectasis and its overlap with other airway diseases, and adult CF.

Scientific Committee member 5
Member · EBROW Scientific Committee

Oriol Sibila

Hospital Clínic de Barcelona, Spain

Head of the Pulmonology Service at Hospital Clínic de Barcelona and accredited researcher in the IDIBAPS group Inflammation and Repair in Respiratory Diseases. His work focuses on airway infection, inflammation and bronchiectasis, including frequent-exacerbator phenotypes in the EMBARC registry.

He coordinates educational programmes on bronchiectasis at Hospital Clínic and publishes widely on mucins, inhaled therapies and treatable traits in chronic airway disease.

Scientific Committee member 2
Member · EBROW Scientific Committee

Natalie Lorent

University Hospital Leuven, Belgium

Natalie Lorent works as a consultant in Respiratory Medicine/Clinical Infectiology at the University Hospital Leuven where since 2015 she coordinates the care for adults with respiratory infections, bronchiectasis (CF and non-CF) and primary ciliary dyskinesia. She is involved in clinical and translational research in bronchiectasis and mycobacterial infections.

She is founder and president of the national NTM Consilium, a clinical advisory board and basis of a national registry; she chairs the European NTM research network (NTMnet) and the Belgian MDRTB expert group. She has been involved in EMBARC since the start. Natalie is also assistant professor at KU Leuven.

Scientific Committee member 3
Member · EBROW Scientific Committee

Felix C. Ringshausen

Hannover Medical School (MHH) and German Center for Lung Research

Felix C. Ringshausen is a board-certified physician for respiratory medicine and infectious diseases and head of the Adult Bronchiectasis and Cystic Fibrosis Service at the Hannover Medical School, Germany. In addition, he is principal investigator of the German Center for Lung Research (DZL).

His research interests are focused on European multidisciplinary networks and multicenter initiatives in order to promote clinically orientated research and improve patient care in the field of rare, neglected and under-researched aspects of respiratory infections like bronchiectasis, nontuberculous mycobacteria, respiratory viruses and adult cystic fibrosis.

Scientific Committee member 1
Member · EBROW Scientific Committee

Stefano Aliberti

Humanitas University, Italy

Professor of Respiratory Medicine, Humanitas University, Milan, Italy. Consultant, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan.

Co-chair of the European Bronchiectasis Network (EMBARC). Chair of IRIDE, the Italian Registry of adult bronchiectasis. Chair of the Italian Registry on Non-Tuberculous Mycobacteria (IRENE).

Michael Loebinger
Co-chair · EBROW Organising Committee

Michael Loebinger

Royal Brompton Hospital · Imperial College London

Professor Michael Loebinger is Professor of Practice at Imperial College London and Director of the Lung Division and Deputy Medical Director at Royal Brompton Hospital. He co-chaired the British Thoracic Society bronchiectasis guidelines and co-wrote the BTS Non-Tuberculous Mycobacteria and European Respiratory Society bronchiectasis guidelines.

He is a founding member of the UK and European clinical and research bronchiectasis and NTM networks and has authored over 200 publications. He has helped design and lead multiple global clinical trials in bronchiectasis and NTM and was chief investigator for the first mRNA trials in primary ciliary dyskinesia.

Charles Haworth
Co-chair · EBROW Organising Committee

Charles Haworth

Royal Papworth Hospital, Cambridge, United Kingdom

Charles Haworth is a Respiratory Consultant working within the Cambridge Centre for Lung Infection at Royal Papworth Hospital where he specialises in treating adults with bronchiectasis, non-tuberculous mycobacterial (NTM) infections and cystic fibrosis.

He co-authored the British Thoracic Society Bronchiectasis clinical guidelines published in 2017 and the European Respiratory Society Bronchiectasis clinical guidelines published in 2019.

He was also senior author of the International Cystic Fibrosis NTM guidelines published in 2015 and first author of the British Thoracic Society NTM guidelines published in 2017.

From 2018 to 2021, he was a founding and executive committee member of the UK Cystic Fibrosis Medical Association.

In June 2024 he was invited to join the Board of the European Cystic Fibrosis Society.

James D. Chalmers
Co-chair · EBROW Organising Committee

James D. Chalmers

University of Oxford, United Kingdom

Rhodes Chair of Experimental Therapeutics and Clinical Pharmacology, University of Oxford.

Chief Editor of the European Respiratory Journal.

Chair of the European Bronchiectasis Network (EMBARC).

Chair of the Standards of Care Committee of the British Thoracic Society.